Results 141 to 150 of about 1,571,897 (161)

[Price effects of global vaccine pooled procurement]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Huang Y, Yu X, Xu M.
europepmc   +1 more source

[Considerations on clinical trial issues related to new drug development for metabolic and alcohol-associated liver disease and fatty liver disease]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Wang XY, Sun HM, Gao YH.
europepmc   +1 more source

[Pathogenic mechanisms and advances in the diagnosis and treatment of co-occurring psychiatric and psychological symptoms in patients with liver cirrhosis]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Gong H, Li YR, Zhang FN, Zhao TT, Huang M, Liu CC, He N.   +6 more
europepmc   +1 more source

[Analysis of the disease burden of Burkitt lymphoma in China from 1990 to 2021]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zheng CH, Wang Y, Chen J, Guo JD, Qi JL, Zhou MG, Song YQ, Zhu J, Liu WP.   +8 more
europepmc   +1 more source

[TACE-HAIC versus HAIC combined with targeted immunotherapy for unresectable hepatocellular carcinoma: a propensity score-matched retrospective controlled study]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Liu C, Zhao M, Li J, Zhao K, Zheng L, Xiao JC.   +5 more
europepmc   +1 more source

[Interpretation of 2024 United Kingdom National Osteoporosis Guideline Group (NOGG) Clinical Guidelines: Prevention and Treatment of Osteoporosis]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Gao J, Wang B, Wang W, Ma J.
europepmc   +1 more source

[Visceral leishmaniasis with suspected autoimmune disease: A report of 2 cases]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Sun F, Chen M, Huo A, Zhang W, Li Z, Cheng L, Liu Y.   +6 more
europepmc   +1 more source

[APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
You H, Maiwall R, Chen J, Ahn HOON, Dokmeci K, Dou XG, El-Sayed M, Fan JG, Gani R, Gao ZL, George J, Ghazinian H, Goh G, Hamid S, Hou JL, Huang SQ, Ji D, Jia JD, Kanda T, Kao JH, Kim YJ, Lesmana RINALDIA, Mohamed R, Ning Q, Ormeci N, Otsuka M, Payawal D, Thuy THANH, Sailey K, Sharma KUMAR, Sollano D, Sun J, Tanwandee T, Thompson A, Wang FS, Wang GQ, Wei L, Wong LL, Wong WS, Yeoh YJ, Yip ZF, Yu ML, Zhang WH, Zhuang H, Lai QL, Omata M, Sarin KUMAR, Lau JJ, APASL Viral Elimination Taskforce.   +48 more
europepmc   +1 more source

[Analysis of epidemiological characteristics and spatial clustering of hepatitis C virus in China from 2018 to 2022]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Fan SF, Zhang JH, Duan ZH, Dai Z, He QY.
europepmc   +1 more source